Abstract B033: Petosemtamab (MCLA-158) monotherapy or with chemotherapy in metastatic colorectal cancer: Preliminary antitumor activity and safety data from a phase 2 trial

Moh'd Khushman; Ruth Vera; Thibault Mazard; DiSean Kendall; Maria Elena Elez; Francesc Salva; Elisa Fontana; Gregory P. Botta; Marcos Melián; Leon Pappas; Ludovic Evesque; Anastasia Murat; Chris Yan; Marina Magin; Gianluca Laus; Fabian Zohren; Josep Tabernero

doi:10.1158/1535-7163.TARG-25-B033

Retour

Abstract B033: Petosemtamab (MCLA-158) monotherapy or with chemotherapy in metastatic colorectal cancer: Preliminary antitumor activity and safety data from a phase 2 trial

Article de revue

Avec comité de lecture

Abstract B033: Petosemtamab (MCLA-158) monotherapy or with chemotherapy in metastatic colorectal cancer: Preliminary antitumor activity and safety data from a phase 2 trial

Moh'd Khushman, Ruth Vera, Thibault Mazard, DiSean Kendall, Maria Elena Elez, Francesc Salva, Elisa Fontana, Gregory P. Botta, Marcos Melián, Leon Pappas, …

Molecular cancer therapeutics, Vol.24(10_Supplement), pp.B033-B033

22/10/2025

DOI: https://doi.org/10.1158/1535-7163.TARG-25-B033

Indicateurs

1 Consultations de la notice

Détails

Titre: Abstract B033: Petosemtamab (MCLA-158) monotherapy or with chemotherapy in metastatic colorectal cancer: Preliminary antitumor activity and safety data from a phase 2 trial
Créateurs - sans rôle: Moh'd Khushman
Ruth Vera
Thibault Mazard
DiSean Kendall
Maria Elena Elez
Francesc Salva
Elisa Fontana
Gregory P. Botta
Marcos Melián
Leon Pappas
Ludovic Evesque
Anastasia Murat
Chris Yan
Marina Magin
Gianluca Laus
Fabian Zohren
Josep Tabernero
Détails de publication: Molecular cancer therapeutics, Vol.24(10_Supplement), pp.B033-B033
Identifiants: 99140027409311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM
Langue: English
Type de ressource: Journal article